...
首页> 外文期刊>Biochemical and Biophysical Research Communications >NOK/STYK1 promotes the genesis and remodeling of blood and lymphatic vessels during tumor progression
【24h】

NOK/STYK1 promotes the genesis and remodeling of blood and lymphatic vessels during tumor progression

机译:NOK / STYK1在肿瘤进展过程中促进血液和淋巴管的形成和重塑

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies have indicated that the overexpression of NOK, also named STYK1, led to tumorigenesis and metastasis. Here, we provide evidence that increased expression of NOK/STYK1 caused marked alterations in the overall and inner structures of tumors and substantially facilitates the genesis and remodeling of the blood and lymphatic vessels during tumor progression. In particular, NOR-expressed HeLa stable cells (HeLa-R) significantly enhanced tumor growth and metastasis in xenografted nude mice. Hematoxylin and eosin (HE) staining demonstrated that the tumor tissues generated by HeLa-K cells were much more ichorous and had more interspaces than those generated by control HeLa cells (HeLa-C). The fluorescent areas stained with cluster of differentiation 31 (CD31), a marker protein for blood vessels, appeared to be in different patterns. The total blood vessels, especially the ring patterns, within the tumors of the HeLa-K group were highly enriched compared with those in the HeLa-C group. NOK-HA was demonstrated to be well colocalized with CD31 in the wall of the tubular structures within tumor tissues. Interestingly, antibody staining of the lymphatic vessel endothelial hyaluronan receptor (LYVE-1) further revealed the increase in ring (oratretic strip-like) lymphatic vessels in either the peri-tumoral or intratumoral areas in the HeLa-K group compared with the HeLa-C group. Consistently, the analysis of human cancerous tissue also showed that NOR was highly expressed in the walls of tubular structures. Thus, our results reveal a novel tumorigenic function of NOK to mediate the genesis and remodeling of blood and lymphatic vessels during tumor progression. (C) 2016 Elsevier Inc. All rights reserved.
机译:先前的研究表明,NOK(也称为STYK1)的过表达导致肿瘤发生和转移。在这里,我们提供的证据表明,NOK / STYK1的表达增加会导致肿瘤的整体和内部结构发生明显变化,并在肿瘤进展过程中大大促进血液和淋巴管的生成和重塑。特别是,在异种移植裸鼠中,NOR表达的HeLa稳定细胞(HeLa-R)显着增强了肿瘤的生长和转移。苏木精和曙红(HE)染色表明,与对照HeLa细胞(HeLa-C)产生的肿瘤相比,HeLa-K细胞产生的肿瘤组织变得更加发老,并且具有更多的间隙。用分化簇31(CD31)(一种血管标记蛋白)染色的荧光区域似乎处于不同的模式。与HeLa-C组相比,HeLa-K组肿瘤内的总血管,尤其是环型非常丰富。已证明,NOK-HA与CD31在肿瘤组织内的管状结构壁中很好地共定位。有趣的是,淋巴管内皮透明质酸受体(LYVE-1)的抗体染色进一步显示,与HeLa-K组相比,HeLa-K组在肿瘤周围或肿瘤内区域的环(原状条状)淋巴管的增加C组。一致地,对人类癌组织的分析还表明,NOR在管状结构的壁中高表达。因此,我们的结果揭示了NOK在肿瘤进展过程中介导血液和淋巴管的发生和重塑的新型致瘤功能。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号